Marksans Pharma Ltd News

Marksans Pharma gains 3% on UK MHRA approval for subsidiary; details here

The upward movement in Marksans Pharma's share price came after the company announced that its wholly owned subsidiary, Relonchem in the UK, had received marketing authorisation for its products